Provider: Macmillian Magazines Ltd.
Content: application/x-research-info-systems
TY  - JOUR
AU  - Feldmann, H.
AU  - Nichol, S. T.
AU  - Klenk, H. D.
AU  - Peters, C. J.
AU  - Sanchez, A.
TI  - Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein.
JA  - Virology
PY  - 1994///
VL  - 199
SP  - 469
EP  - 473
M3  - 10.1006/viro.1994.1147
N1  - 10.1006/viro.1994.1147
UR  - http://dx.doi.org/10.1006/viro.1994.1147
ER  -

TY  - JOUR
AU  - Sanchez, A.
AU  - Trappier, S. G.
AU  - Mahy, B. W. J.
AU  - Peters, C. J.
AU  - Nichol, S. T.
TI  - The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.
JA  - Proc. Natl Acad. Sci. USA
PY  - 1996///
VL  - 93
SP  - 3602
EP  - 3607
M3  - 10.1073/pnas.93.8.3602
N1  - 10.1073/pnas.93.8.3602
UR  - http://dx.doi.org/10.1073/pnas.93.8.3602
ER  -

TY  - JOUR
AU  - Tang, D. C.
AU  - DeVit, M.
AU  - Johnston, S. A.
TI  - Genetic immunization is a simple method for eliciting an immune response.
JA  - Nature
PY  - 1992///
VL  - 356
SP  - 152
EP  - 154
M3  - 10.1038/356152a0
N1  - 10.1038/356152a0
UR  - http://dx.doi.org/10.1038/356152a0
ER  -

TY  - JOUR
AU  - Ulmer, J. B.
TI  - Heterologous protection against influenza by injection of DNA encoding a viral protein.
JA  - Science
PY  - 1993///
VL  - 259
SP  - 1745
EP  - 1749
ER  -

TY  - JOUR
AU  - Wang, B.
TI  - Gene inoculation generates immune responses against human immunodeficiency virus type 1.
JA  - Proc. Natl Acad. Sci. USA
PY  - 1993///
VL  - 90
SP  - 4156
EP  - 4160
ER  -

TY  - JOUR
AU  - Sedegah, M.
AU  - Hedstrom, R.
AU  - Hobart, P.
AU  - Hoffman, S. L.
TI  - Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
JA  - Proc. Natl Acad. Sci. USA
PY  - 1994///
VL  - 91
SP  - 9866
EP  - 9870
ER  -

TY  - JOUR
AU  - Krieg, A. M.
TI  - CpG motifs in bacterial DNA trigger direct B-cell activation.
JA  - Nature
PY  - 1995///
VL  - 374
SP  - 546
EP  - 549
M3  - 10.1038/374546a0
N1  - 10.1038/374546a0
UR  - http://dx.doi.org/10.1038/374546a0
ER  -

TY  - JOUR
AU  - Sato, Y.
TI  - Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.
JA  - Science
PY  - 1996///
VL  - 273
SP  - 352
EP  - 354
ER  -

TY  - JOUR
AU  - Xu, L.
TI  - Immunization for Ebola virus infection.
JA  - Nature Med.
PY  - 1998///
VL  - 4
SP  - 37
EP  - 42
M3  - 10.1038/nm0198-037
N1  - 10.1038/nm0198-037
UR  - http://dx.doi.org/10.1038/nm0198-037
ER  -

TY  - JOUR
AU  - Vanderzanden, L.
TI  - DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge.
JA  - Virology
PY  - 1998///
VL  - 246
SP  - 134
EP  - 144
M3  - 10.1006/viro.1998.9176
N1  - 10.1006/viro.1998.9176
UR  - http://dx.doi.org/10.1006/viro.1998.9176
ER  -

TY  - JOUR
AU  - Connolly, B. M.
TI  - Pathogenesis of experimental Ebola virus infection in guinea pigs.
JA  - J. Infect. Dis.
PY  - 1999///
VL  - 179
SP  - S203
EP  - S217
ER  -

TY  - JOUR
AU  - Bray, M.
AU  - Davis, K.
AU  - Geisbert, T.
AU  - Schmaljohn, C.
AU  - Huggins, J.
TI  - A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.
JA  - J. Infect. Dis.
PY  - 1998///
VL  - 178
SP  - 651
EP  - 661
ER  -

TY  - JOUR
AU  - Baize, S.
TI  - Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.
JA  - Nature Med.
PY  - 1999///
VL  - 5
SP  - 423
EP  - 426
ER  -

TY  - JOUR
AU  - Maruyama, T.
TI  - Ebola virus can be effectively neutralized by antibody produced in natural human infection.
JA  - J. Virol.
PY  - 1999///
VL  - 73
SP  - 6024
EP  - 6030
ER  -

TY  - JOUR
AU  - Sedegah, M.
TI  - Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
JA  - Proc. Natl Acad. Sci. USA
PY  - 1998///
VL  - 95
SP  - 7648
EP  - 7653
M3  - 10.1073/pnas.95.13.7648
N1  - 10.1073/pnas.95.13.7648
UR  - http://dx.doi.org/10.1073/pnas.95.13.7648
ER  -

TY  - JOUR
AU  - Hanke, T.
TI  - Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime.
JA  - Vaccine
PY  - 1998///
VL  - 16
SP  - 439
EP  - 445
M3  - 10.1016/S0264-410X(97)00226-0
N1  - 10.1016/S0264-410X(97)00226-0
UR  - http://dx.doi.org/10.1016/S0264-410X(97)00226-0
ER  -

TY  - JOUR
AU  - Robinson, H. L.
TI  - Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.
JA  - Nature Med.
PY  - 1999///
VL  - 5
SP  - 526
EP  - 534
ER  -

TY  - JOUR
AU  - Schneider, J.
TI  - Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
JA  - Nature Med.
PY  - 1998///
VL  - 4
SP  - 397
EP  - 402
M3  - 10.1038/nm0498-397
N1  - 10.1038/nm0498-397
UR  - http://dx.doi.org/10.1038/nm0498-397
ER  -

TY  - JOUR
AU  - Davis, A. R.
TI  - Expression of hepatitis B surface antigen with a recombinant adenovirus.
JA  - Proc. Natl Acad. Sci. USA
PY  - 1985///
VL  - 82
SP  - 7560
EP  - 7564
ER  -

TY  - JOUR
AU  - Natuk, R. J.
TI  - Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model.
JA  - Proc. Natl Acad. Sci. USA
PY  - 1992///
VL  - 89
SP  - 7777
EP  - 7781
ER  -

TY  - JOUR
AU  - Xiang, Z. Q.
AU  - Yang, Y.
AU  - Wilson, J. M.
AU  - Ertl, H. C.
TI  - A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
JA  - Virology
PY  - 1996///
VL  - 219
SP  - 220
EP  - 227
M3  - 10.1006/viro.1996.0239
N1  - 10.1006/viro.1996.0239
UR  - http://dx.doi.org/10.1006/viro.1996.0239
ER  -

TY  - JOUR
AU  - Xiang, Z. Q.
AU  - Pasquini, S.
AU  - Ertl, H. C.
TI  - Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.
JA  - J. Immunol.
PY  - 1999///
VL  - 162
SP  - 6716
EP  - 6723
ER  -

TY  - JOUR
AU  - Letvin, N. L.
TI  - Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.
JA  - Proc. Natl Acad. Sci. USA
PY  - 1997///
VL  - 94
SP  - 9378
EP  - 9383
M3  - 10.1073/pnas.94.17.9378
N1  - 10.1073/pnas.94.17.9378
UR  - http://dx.doi.org/10.1073/pnas.94.17.9378
ER  -

TY  - JOUR
AU  - Fisher-Hoch, S. P.
TI  - Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).
JA  - J. Infect. Dis.
PY  - 1985///
VL  - 152
SP  - 887
EP  - 894
ER  -

TY  - JOUR
AU  - Wilson, J.
TI  - Epitopes involved in antibody-mediated protection from Ebola virus.
JA  - Science
PY  - 2000///
VL  - 287
SP  - 1664
EP  - 1666
M3  - 10.1126/science.287.5458.1664
N1  - 10.1126/science.287.5458.1664
UR  - http://dx.doi.org/10.1126/science.287.5458.1664
ER  -

TY  - JOUR
AU  - Ohno, T.
TI  - Gene therapy for vascular smooth muscle cell proliferation after arterial injury.
JA  - Science
PY  - 1994///
VL  - 265
SP  - 781
EP  - 784
ER  -

TY  - JOUR
AU  - Aoki, K.
AU  - Barker, C.
AU  - Danthinne, X.
AU  - Imperiale, M. J.
AU  - Nabel, G. J.
TI  - Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro.
JA  - Mol. Med.
PY  - 1999///
VL  - 5
SP  - 224
EP  - 231
ER  -

TY  - JOUR
AU  - Ksiazek, T. G.
TI  - Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates.
JA  - J. Clin. Microbiol.
PY  - 1992///
VL  - 30
SP  - 947
EP  - 950
ER  -

TY  - JOUR
AU  - Kiley, M. P.
AU  - Regnery, R. L.
AU  - Johnson, K. M.
TI  - Ebola virus: identification of virion structural proteins.
JA  - J. Gen. Virol.
PY  - 1980///
VL  - 49
SP  - 333
EP  - 341
ER  -